
Peptides
Subcategories of "Peptides"
Found 29860 products of "Peptides"
TNFRSF4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TNFRSF4 antibody, catalog no. 70R-9666Purity:Min. 95%TCF25 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TCF25 antibody, catalog no. 20R-1266
Purity:Min. 95%ARHGAP28 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARHGAP28 antibody, catalog no. 70R-3943
Purity:Min. 95%SLC25A32 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC25A32 antibody, catalog no. 70R-6474
Purity:Min. 95%SLC27A4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC27A4 antibody, catalog no. 70R-7204
Purity:Min. 95%Galanin (Human)
CAS:Galanin is a peptide that belongs to the family of neuropeptides and is found in the endocrine system, the central and peripheral nervous systems. It has been shown to inhibit the release of acetylcholine in the central nervous system and interestingly in Alzheimer’s disease patients, hyperinervation of galanin fibres has been found. Galanin is also known to have a variety of physiological effects including inhibition of insulin release, stimulation of prolactin and growth hormone secretion and it also plays a role in feeding, mood, cognition, neuroendocrine regulation and affects gastrointestinal motility. Galanin asserts its effects through associated with G-protein coupled receptors. This product is available as a 0.5mg vial.
Formula:C139H210N42O43Purity:Min. 95%Molecular weight:3,157.4 g/molUMPS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UMPS antibody, catalog no. 70R-2670
Purity:Min. 95%SFT2D3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SFT2D3 antibody, catalog no. 70R-10139
Purity:Min. 95%DPYSL2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DPYSL2 antibody, catalog no. 70R-5234
Purity:Min. 95%IGSF9 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IGSF9 antibody, catalog no. 70R-7213
Purity:Min. 95%ALDH1B1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ALDH1B1 antibody, catalog no. 70R-3238
Purity:Min. 95%HNF4A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HNF4A antibody, catalog no. 70R-2034
Purity:Min. 95%MIER2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MIER2 antibody, catalog no. 70R-4353
Purity:Min. 95%IGFBP4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IGFBP4 antibody, catalog no. 70R-5309
Purity:Min. 95%Biotin-MAGE-A2 (157-166)
Biotin-MAGE-A2 (157-166) is the N-ter biotinylated version of MAGE-A2 (157-166). Biotin-MAGE-A2 (157-166) can be used in the analysis of antigen-specific T cells. MAGE-A2 protein:
MAGE-A2 (157-166) is an epitope of Melanoma Antigen Gene A2 and is one of the most Cancer-Testis Antigens (CTA) overexpressed in tumors of different histological types, such as prostate cancer. Type of MAGE-A expressed in tumors cells varies according to the type of tumor. The expression of MAGE-A2 causes the proliferation of prostate cancer cells and decreases the chemosensitivity.
Applications of MAGE-A2 (157-166):
MAGE-A2 (157-166) is used to stimulate specific immune response, cytotoxic T cell response and to analyze the cytokine production in PBMCs by ELISPOT assay. In transgenic mouse, it has been demonstrated that MAGE-A2 (157-166) was capable of eliciting a CTL response presented by HLA-A*02:01 molecules. MAGE-A2 (157-166) has been reported to elicit CTL that could lyse tumor cell expressing both HLA-A*02:01 and MAGE-A2 by stimulation of peripheral blood mononuclear cells (PBMCs) with MAGE-A2 (157-166).
Sequence: Biotin-YLQLVFGIEVNHS-dPEG®4-( m-dPEG®12)3-Ester
CAS:NHS-dPEG®4-( m-dPEG®12)3-Ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. NHS-dPEG®4-( m-dPEG®12)3-Ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.
Formula:C58H106N6O26Purity:Min. 95%Molecular weight:1,303.49 g/molC17ORF64 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C17orf64 antibody, catalog no. 70R-3321
Purity:Min. 95%Fbxo34 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Fbxo34 antibody, catalog no. 70R-9473
Purity:Min. 95%Wdr92 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Wdr92 antibody, catalog no. 70R-9191
Purity:Min. 95%CHCHD3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CHCHD3 antibody, catalog no. 70R-4355
Purity:Min. 95%
